Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000927417 | SCV001073001 | likely benign | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505375 | SCV002796235 | likely benign | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | 2022-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000927417 | SCV004144796 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | LAMA1: BP4, BP7 |
Clinical Genetics, |
RCV000927417 | SCV001978905 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000927417 | SCV001980423 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004551873 | SCV004781446 | likely benign | LAMA1-related disorder | 2019-09-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |